Navigation Links
Independent Pharmacy Cooperative to Distribute Promescent, Topical Medication for Premature Ejaculation
Date:6/14/2013

HUNTINGTON BEACH, Calif., June 14, 2013 /PRNewswire/ -- The Independent Pharmacy Cooperative (IPC) and Absorption Pharmaceuticals (AP) have signed a distribution agreement whereby IPC will make AP's topical treatment for premature ejaculation, Promescent, available to its 4,500+ member pharmacies throughout the United States.

Promescent is fast becoming first-line therapy for premature ejaculation by numerous urologists and Large Urology Groups Practice Association (LUGPA) members across the U.S., replacing off-label medications which have known side effects. Promescent is available over-the-counter by way of FDA monograph 21 CFR 348.10 and has minimal risk of systemic side effects. The effectiveness, ease-of-use, safety, and low cost per dose of the medication are key reasons for its rise in popularity among physicians.

"Urologists want their patients to have convenient and private locations for obtaining Promescent after their office visit," says Jeff Abraham, CEO of Absorption Pharmaceuticals. "The relationship with IPC now gives patients in virtually every location in the country the fast and confidential access to what has become a mainstream medication for PE."

Many independent pharmacies provide compounding services such as Trimix for erectile dysfunction.  Some urologists who prescribe Trimix and other injection therapies for ED are recommending Promescent to these patients in order to achieve a better overall sexual experience.

"We have witnessed a steady growth in product demand since our first member pharmacy started  carrying Promescent," says Dean Slaugenhoup, director of contracts and purchasing at IPC . "Our mission at IPC is to provide our members cost-effective and convenient access to products that have passed a threshold of acceptance by physicians and Promescent is now clearly in this category. It was time to formalize the relationship."

IPC is now stocking Promescent at its two distribution centers and making members aware of the Promescent's availability.

About Absorption Pharmaceuticals

Absorption Pharmaceuticals, based in Huntington Beach, California, is the maker of Promescent, the world's first FDA-approved topical treatment for premature ejaculation.  Promescent is now first-line PE therapy for numerous urologists and sexual medicine experts throughout the United States and Canada.  Visit www.promescent.com.

About Independent Pharmacy Cooperative (IPC)

Over the past 30 years, IPC has evolved into the nation's largest group purchasing organization for independent pharmacies. IPC represents over 4500 pharmacy members. Located in Sun Prairie, WI and staffed by 75 employees, IPC prides itself on providing the most progressive and effective programs and services to put profit back in the independent pharmacy.

Contact: Greg Kaminski, +1-412-741-1430, greg.kaminski@promescent.com


'/>"/>
SOURCE Absorption Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
2. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
3. Managed Health Care Associates, Inc. (MHA) Released Results of Sixth Annual Independent Long Term Care Member Study with Expanded Specialty Pharmacy Findings
4. Agnitio Launches Rainmaker One to Remove the Complexity of Managing Independent Apps
5. Independent Drugstore Lobby Wants Sweeping Antitrust Exemptions to Charge Higher Prescription Drug Prices
6. Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
7. China Botanic Appoints Jack Zhao as Independent Director
8. PQ Bypass Graduates from the Fogarty Institute for Innovation, Establishes Independent Operations
9. H. D. Smith Supports Local Hospitals, Nursing Homes, Clinics And Independent Retail Pharmacies Throughout Hurricane Sandy
10. Registry Data Shows 90% Of Patients Independent, Free Of Significant Disabilities After Treatment With Codman System For Wide-necked Aneurysms
11. 3SBio Independent Committee Selects Legal Counsel in connection with Going Private Proposal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... April 29, 2016 ReportsnReports.com ... 2016" market research report that provides an overview ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
(Date:4/29/2016)... April 29, 2016 Automation is ... laboratory due to the growing demands for productivity in ... contemporary automated systems are already adept of a wide ... tedious and manual labor. Instrumentation continues to evolve, and ... conceivable just a few years ago. Originally used mostly ...
(Date:4/28/2016)... BURLINGAME, Calif. , April 28, 2016 /PRNewswire/ ... first-ever widely accessible breast and ovarian cancer risk ... cancer panel analyzing 30 genes that highly impact ... and women. Available today, the Color Test analyzes ... pancreatic, prostate, stomach, and uterine cancers. The Color ...
Breaking Medicine Technology:
(Date:5/3/2016)... NY (PRWEB) , ... May 04, 2016 , ... ... a 2016-2017 inductee into its VIP Woman of the Year Circle. She is recognized ... organization exclusively for professional women, boasting more than 850,000 members and over 200 operating ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... 2016 Champion Award to Charles D. Pulido, R.Ph., Co-Founder of NCPDP and member ... Ph.D., Pharmacy Advisor and Health IT Specialist, Office of the National Coordinator for ...
(Date:5/3/2016)... ... 2016 , ... California health startup Pegara announced today the ... assess their risk of developing Alzheimer’s disease. Using a questionnaire based on years ... Score™” that summarizes how their lifestyle choices may affect their chances of developing ...
(Date:5/3/2016)... CA (PRWEB) , ... May 03, 2016 , ... ... is a process that selects DNA or RNA from a random library of ... potentially be used as drugs or diagnostic agents. SELEX selection is commonly performed ...
(Date:5/3/2016)... Fla. (PRWEB) , ... May 03, 2016 , ... Elizabeth ... her pet parrots to join her with one on her shoulder and one on ... through a parking lot because of years of mitral valve prolapse. , The valves ...
Breaking Medicine News(10 mins):